Studies

"Studies" include those bills, subject-matter or self-initiated inquiries, Estimates and other matters referred by the House that the Committee has studied during the current session. On the page for a particular study, you will find, where applicable: a list of meetings, reports and responses, witnesses, news releases and documents related to the study.

• Avian flu
• Bill C-12, An Act to prevent the introduction and spread of communicable diseases
• Bill C-206, An Act to amend the Food and Drugs Act (warning labels regarding the consumption of alcohol)
• Bill C-28, An Act to amend the Food and Drugs Act (interim marketing authorizations)
• Bill C-420, An Act to amend the Food and Drugs Act (definitions of "drug" and "food")
• Canadian Strategy for Cancer Control
• Canadian Strategy on HIV/AIDS
• Certificate of nomination of Alan Bernstein to the position of President of the Canadian Institutes of Health Research
• External Performance Audits
• Internet Pharmacies
• Main Estimates 2005-2006: Votes 1, 5, 10, 15, 20, 25, 30 and 35 under HEALTH
• New strategy for the prevention of Fetal Alcohol Spectrum Disorder
• Proposed Cigarette Ignition Propensity Regulations
• Proposed Regulations Amending the Tobacco Reporting Regulations
• Report of the Auditor General of Canada (Chapter 4: Management of Federal Drug Benefit Programs)
• Silicone gel-filled breast implants
• Study on Prescription Drugs
• Tobacco issues related to compliance with the Tobacco Act, cigarette smuggling and combating tobacco use

Activities

"Activities" include business items for which the committee meets and may take action, but which are not "studies" as such. "Activities" include proceedings to elect the committee chair, to discuss future business, and meetings with delegations, when the meeting is not related to a particular item under study by the committee.

• Briefing on the status of the regulations for the Assisted Human Reproduction Act
• Briefing session on Natural Health Products
• Briefing session on organ transplants
• Briefing session on the Assisted Human Reproduction Implementation Office
• Briefing session on the Canadian Patient Safety Institute and the Canadian Adverse Events Study
• Briefing session on the circumstances around the firing of three Health Canada researchers
• Briefing session on the Health Council of Canada
• Briefing session on the Public Health Agency
• Briefing session on the Ten-Year Plan to Strengthen Health Care
• Briefing session on the Trans Fat Task Force
• Committee Business
• Election of Chair
• Hepatitis C